全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Historical Evolution of Fluid Therapy and Contemporary Challenges: From Intravenous Injection to Artificial Blood

DOI: 10.4236/ojanes.2025.1512025, PP. 326-369

Keywords: Fluid Therapy, Blood Transfusion, Plasma Substitutes, Ringer’s Solution, Enhanced Recovery After Surgery (ERAS), Perioperative Management, Artificial Blood

Full-Text   Cite this paper   Add to My Lib

Abstract:

Fluid therapy has evolved dramatically from its origins in 17th-century blood transfusion experiments to sophisticated, modern, perioperative fluid management protocols. This comprehensive review traces the historical development of intravenous fluid administration, beginning with William Harvey’s circulation theory and Christopher Wren’s pioneering venous injections, through the cholera epidemics that necessitated early fluid replacement therapy, to Sydney Ringer’s groundbreaking electrolyte solutions. The evolution of blood transfusion from dangerous animal-to-human experiments to safe ABO-compatible transfusions paralleled the development of plasma substitutes and colloid solutions. Pediatric fluid therapy emerged as a specialized field in the early 20th century, with contributions from researchers like James Gamble and Daniel Darrow establishing the fundamental principles of water and electrolyte balance. Modern perioperative fluid management has been revolutionized by Enhanced Recovery After Surgery (ERAS) protocols, goal-directed fluid therapy, and evidence-based approaches that optimize patient outcomes. Contemporary challenges include the ongoing debate over crystalloid versus colloid solutions, the safety concerns surrounding hydroxyethyl starch preparations, and the continued quest for effective artificial blood substitutes. Recent advances in artificial oxygen carriers, particularly Professor Hiromi Sakai’s hemoglobin vesicles (HbV) developed through three decades of research at Nara Medical University, have demonstrated promising Phase 1 trial results with acceptable safety profiles, offering potential solutions to blood supply shortages and compatibility issues with anticipated clinical implementation by 2030. This historical perspective illuminates how empirical observations evolved into evidence-based practice, while highlighting persistent challenges in optimizing fluid therapy for diverse clinical scenarios.

References

[1]  Harvey, W. and De Landau, H. (1628) Exercitatio anatomica de motv cordis et sangvinis in animalibvs. William Fitzer.
https://doi.org/10.5479/sil.126677.39088002685501

[2]  Snow, J. (1855) On the Mode of Communication of Cholera. John Churchill.
[3]  Breasted, J.H. (1930) The Edwin Smith Surgical Papyrus. University of Chicago Press.
[4]  Ghalioungui, P. (1987) The Ebers Papyrus: A New English Translation. Academy of Scientific Research.
[5]  Iskandar, A.Z. (1962) Al-Razi’s Contribution to Medicine. Medical History, 6, 126-133.
[6]  Aciduman, A. and Er, U. (2007) Avicenna’s Views on Brain Anatomy, Intracranial Diseases, and Their Treatment. Neurosurg Focus, 23, E8.
[7]  O’Malley, C.D. (1964) Andreas Vesalius of Brussels, 1514-1564. University of California Press.
[8]  Bainton, R.H. (1953) Hunted Heretic: The Life and Death of Michael Servetus. Beacon Press.
[9]  Whitteridge, G. (1971) William Harvey and the Circulation of the Blood. Mac-Donald.
[10]  Wren, C. (1665) Experiments on the Injection of Liquors into the Veins of Animals. Philosophical Transactions of the Royal Society of London, 1, 128-130.
[11]  Boyle, R. (1663) Some Considerations Touching the Usefulness of Experimental Natural Philosophy. Henry Herringman.
[12]  Frank, H.A. (2000) Robert Boyle: Pioneer of Transfusion Medicine. Transfusion Medicine Reviews, 14, 213-221.
[13]  Hoff, H.E. and Guillemin, R. (1963) The First Experiments in Intravenous Therapy: Christopher Wren’s Contributions. Journal of the History of Medicine and Allied Sciences, 18, 13-21.
[14]  Schmidt, J.E. (1959) Medical Discoveries: Who and When. Charles C Thomas.
[15]  Cosnett, J.E. (1989) The Origins of Intravenous Fluid Therapy. The Lancet, 333, 768-771.
https://doi.org/10.1016/s0140-6736(89)92583-x

[16]  Major, J.D. (1664) Chirurgia Infusoria. Joachim Reumann.
[17]  Garrison, F.H. (1929) An Introduction to the History of Medicine. W.B. Saunders.
[18]  Elsholtz, J.S. (1665) Clysmatica Nova. Georg Schultz.
[19]  Magendie, F. (1824) Formulary for the Preparation and Mode of Employing Several New Remedies. Thomas and George Underwood.
[20]  Olmsted, J.M.D. (1944) François Magendie: Pioneer in Experimental Physiology and Scientific Medicine in XIX Century France. Schuman.
[21]  Porter, R. (1997) The Greatest Benefit to Mankind: A Medical History of Humanity. Norton.
[22]  Temkin, O. (1973) Galenism: Rise and Decline of a Medical Philosophy. Cornell University Press.
[23]  Singer, C. and Underwood, E.A. (1962) A Short History of Medicine. Oxford University Press.
[24]  Hales, S. (1733) Statistical Essays: Containing Haemastaticks. W. Innys and R. Manby.
[25]  Allan, D.J. and Schofield, R.E. (1980) Stephen Hales: Scientist and Philanthropist. Scholar Press.
[26]  French, R. (1994) William Harvey’s Natural Philosophy. Cambridge University Press.
[27]  David, T.E. (1975) Blood and Wine: The Religious and Symbolic Association in Antiquity. Journal of the History of Medicine and Allied Sciences, 30, 263-276.
[28]  Scarborough, J. (1968) Roman Medicine and the Legions: A Reconsideration. Medical History, 12, 254-261.
https://doi.org/10.1017/s0025727300013296

[29]  Lower, R. (1665) The Method Observed in Transfusing the Blood Out of One Animal into Another. Philosophical Transactions of the Royal Society of London, 1, 353-358.
[30]  Hooke, R. (1667) Method of Preserving Animals Alive by Blowing through Their Lungs with Bellows. Philosophical Transactions of the Royal Society of London, 2, 539-540.
[31]  Lower, R. (1669) Tractatus de Corde. Jo. Redmayne.
[32]  Keynes, G. (1949) Blood Transfusion. John Wright & Sons.
[33]  Denis, J.B. (1667) Letter Concerning a New Way of Curing Sundry Diseases by Transfusion of Blood. Philosophical Transactions of the Royal Society of London, 2, 489-504.
[34]  Maluf, N.S.R. (1954) History of Blood Transfusion. Journal of the History of Medicine and Allied Sciences, IX, 59-107.
https://doi.org/10.1093/jhmas/ix.1.59

[35]  Tucker, H.H. (2011) Blood Work: A Tale of Medicine and Murder in the Scientific Revolution. W.W. Norton.
[36]  Denis, J.B. (1668) Lettre écrite à monsieur montmort par monsieur denis touchant une folie invétérée qui a été guérie par la transfusion du sang. Journal des Savants, 3, 153-159.
[37]  King, E. (1667) An Account of the Experiment of Transfusion Practiced Upon a Man in London. Philosophical Transactions of the Royal Society of London, 2, 557-559.
[38]  Mollison, P.L. (1972) Blood Transfusion in Clinical Medicine. Blackwell Scientific.
[39]  Blundell, J. (1818) Experiments on the Transfusion of Blood by the Syringe. Journal of the Royal Society of Medicine, 9, 56-92.
https://doi.org/10.1177/09595287180090p107

[40]  Young, J.H. (1964) James Blundell (1790-1878) Experimental Physiologist and Obstetrician. Medical History, 8, 159-169.
https://doi.org/10.1017/s0025727300029409

[41]  Blundell, J. (1819) Some Account of a Case of Obstinate Vomiting, in Which an Attempt Was Made to Prolong Life by the Injection of Blood into the Veins. Journal of the Royal Society of Medicine, 10, 296-311.
https://doi.org/10.1177/09595287190100p204

[42]  Blundell, (1828) Observations on Transfusion of Blood. The Lancet, 12, 321-324.
https://doi.org/10.1016/s0140-6736(02)92543-2

[43]  Blundell, J. (1980) The First Human Blood Transfusion. American Journal of Obstetrics & Gynecology, 136, 985-987.
[44]  Blundell, J. (1825) Researches Physiological and Pathological. E. Cox.
[45]  Blundell, J. (1829) Successful Case of Transfusion. The Lancet, 1, 431-432.
[46]  Landsteiner, K. (1900) Zur kenntnis der antifermentativen, lytischen und agglutinierenden wirkungen des blutserums und der lymphe. Centralbl Bakteriol, 27, 357-362.
[47]  Landsteiner, K. (1961) On Agglutination of Normal Human Blood. Transfusion, 1, 5-8.
https://doi.org/10.1111/j.1537-2995.1961.tb00005.x

[48]  Schiff, F. (1950) The ABO Blood Groups and Their Significance. Vox Sanguinis, 5, 1-14.
[49]  Stormont, C. (1968) The ABO Blood Groups: An Appreciation of Karl Landsteiner. California Medicine, 109, 285-292.
[50]  von Decastello, A. and Sturli, A. (1902) Ueber die isoagglutinine im serum gesunder und kranker menschen. Münchner Medizinische Wochenschrift, 49, 1090-1095.
[51]  Wiener, A.S. (1946) The Rh Factor and Racial Origins. American Journal of Physical Anthropology, 4, 1-8.
[52]  Landsteiner, K. and Wiener, A.S. (1940) An Agglutinable Factor in Human Blood Recognized by Immune Sera for Rhesus Blood. Experimental Biology and Medicine, 43, 223-223.
https://doi.org/10.3181/00379727-43-11151

[53]  Wiener, A.S. (1943) Genetic Theory of the Rh Blood Types. Experimental Biology and Medicine, 54, 316-319.
https://doi.org/10.3181/00379727-54-14419

[54]  Coombs, R.R.A., Mourant, A.E. and Race, R.R. (1945) A New Test for the Detection of Weak and Incomplete Rh Agglutinins. British Journal of Experimental Pathology, 26, 255-266.
[55]  Hustin, A. (1914) Principe d’une nouvelle méthode de transfusion muqueuse. Journal de Médecine de Bruxelles, 12, 436-439.
[56]  Keynes, G. (1943) The History of Blood Transfusion, 1628-1914. Journal of British Surgery, 31, 38-50.
https://doi.org/10.1002/bjs.18003112107

[57]  Cohn, E.J., Strong, L.E., Hughes, W.L., Mulford, D.J., Ashworth, J.N., Melin, M., et al. (1946) Preparation and Properties of Serum and Plasma Proteins. Journal of the American Chemical Society, 68, 459-475.
https://doi.org/10.1021/ja01207a034

[58]  Fantus, B. (1937) The Therapy of the Cook County Hospital Blood Bank. JAMA, 109, 128-131.
[59]  DeGowin, R.L. (1982) A Brief History of Blood Transfusion. In: DeGowin, R.L., Ed., Blood Transfusion, Little Brown, 1-18.
[60]  Drew, C.R. (1940) Banked Blood: A Study in Blood Preservation. Doctoral Dissertation, Columbia University.
[61]  Love, W.C. (1969) Charles Richard Drew (1904-1950): His Contributions to Blood Transfusion. Journal of the National Medical Association, 61, 467-469.
[62]  Walter, C.W. and Murphy Jr., W.P., A. (1952) Closed Gravity Technique for the Preservation of Whole Blood in ACD Solution Utilizing Plastic Equipment. Surgery, Gynecology & Obstetrics, 94, 687-692.
[63]  Gibson, J.G., Peacock, W.C., Seligman, A.M. and Sack, T. (1946) Circulating Red Cell Volume Measured Simultaneously by the Radioactive Iron and Dye Methods. Journal of Clinical Investigation, 25, 838-847.
https://doi.org/10.1172/jci101771

[64]  Starling, E.H. (1896) On the Absorption of Fluids from the Connective Tissue Spaces. The Journal of Physiology, 19, 312-326.
https://doi.org/10.1113/jphysiol.1896.sp000596

[65]  Pappenheimer, J.R. and Soto-Rivera, A. (1948) Effective Osmotic Pressure of the Plasma Proteins and Other Quantities Associated with the Capillary Circulation in the Hindlimbs of Cats and Dogs. American Journal of Physiology-Legacy Content, 152, 471-491.
https://doi.org/10.1152/ajplegacy.1948.152.3.471

[66]  Duran Jorda, F. (1939) The Barcelona Blood-Transfusion Service. The Lancet, 233, 773-775.
https://doi.org/10.1016/s0140-6736(00)60392-6

[67]  Eliasson, R. (1952) Blood and Plasma Substitutes. Acta Physiologica Scandinavica, 25, 1-191.
[68]  Janeway, C.A., Gibson, S.T., Woodruff, L.M., Heyl, J.T., Bailey, O.T. and Newhouser, L.R. (1944) Chemical, Clinical, and Immunological Studies on the Products of Human Plasma Fractionation. VII. Concentrated Human Serum Albumin 123. Journal of Clinical Investigation, 23, 465-490.
https://doi.org/10.1172/jci101514

[69]  Jenkins, M.T., Gottlieb, L.S., Choi, S. and Rosenberg, B.J. (1962) Gelatin as a Plasma Substitute: A Clinical Evaluation. Anesthesia & Analgesia, 41, 314-318.
[70]  Wilson, C.W. (1948) Fluorescence of Highly Insulating Dielectrics Produced by X-and Γ-radiations. Nature, 161, 520-521.
https://doi.org/10.1038/161520b0

[71]  Grönwall, A. and Ingelman, B. (1945) Untersuchungen über dextran und sein verhalten bei parenteraler zufuhr. II. Acta Physiologica Scandinavica, 9, 1-27.
https://doi.org/10.1111/j.1748-1716.1945.tb03080.x

[72]  Hint, H. (1968) The Pharmacology of Dextran and the Physiological Background for the Clinical Use of Rheomacrodex and Macrodex. Acta Anaesthesiologica Belgica, 19, 119-138.
[73]  Bergentz, S.E., Gelin, L.E., Rudenstam, J., et al. (1961) Dextran in the Treatment of Shock. The New England Journal of Medicine, 264, 1230-1233.
[74]  Bergström, K., Hedner, U. and Nilsson, I.M. (1961) Dextran and Blood Coagulation. Thrombosis, Death & Haemorrhage, 6, 15-29.
[75]  Thompson, W.L., Fukushima, T., Rutherford, R.B. and Walton, R.P. (1970) Intravascular Persistence, Tissue Storage, and Excretion of Hydroxyethyl Starch. Surgery, Gynecology & Obstetrics, 131, 965-972.
[76]  Walton, R.P., Thompson, W.L. and Sedar, A.W. (1973) Efficacy of Hydroxyethyl Starch Compared with Albumin for Postoperative Volume Expansion. Anesthesiology, 38, 461-463.
[77]  Lowe, G.D.O., Forbes, C.D., Prentice, C.R.M., et al. (1977) Comparison of Effects of Modified Gelatin and Dextran 70 on Coagulation and Fibrinolysis. British Medical Journal, 2, 517-519.
[78]  Lundsgaard-Hansen, P. (1980) Component Therapy of Surgical Hemorrhage: Red Cell Concentrates, Colloids and Crystalloids. Bibliotheca Haematologica, 46, 147-169.
https://doi.org/10.1159/000430555

[79]  Vogt, N.H., Bothner, U., Lerch, G., Lindner, K.H. and Georgieff, M. (1996) Large-dose Administration of 6% Hydroxyethyl Starch 200/0.5 for Total Hip Arthroplasty. Anesthesia & Analgesia, 83, 262-268.
https://doi.org/10.1213/00000539-199608000-00011

[80]  Perner, A., Haase, N., Guttormsen, A.B., Tenhunen, J., Klemenzson, G., Åneman, A., et al. (2012) Hydroxyethyl Starch 130/0.42 versus Ringer’s Acetate in Severe Sepsis. New England Journal of Medicine, 367, 124-134.
https://doi.org/10.1056/nejmoa1204242

[81]  Brunkhorst, F.M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., et al. (2008) Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis. New England Journal of Medicine, 358, 125-139.
https://doi.org/10.1056/nejmoa070716

[82]  Myburgh, J.A., Finfer, S., Bellomo, R., Billot, L., Cass, A., Gattas, D., et al. (2012) Hydroxyethyl Starch or Saline for Fluid Resuscitation in Intensive Care. New England Journal of Medicine, 367, 1901-1911.
https://doi.org/10.1056/nejmoa1209759

[83]  Zarychanski, R., Abou-Setta, A.M., Turgeon, A.F., Houston, B.L., McIntyre, L., Marshall, J.C., et al. (2013) Association of Hydroxyethyl Starch Administration with Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation: A Systematic Review and Meta-Analysis. JAMA, 309, 678-688.
https://doi.org/10.1001/jama.2013.430

[84]  European Medicines Agency (2013) Hydroxyethyl-Starch Solutions (HES) No Longer to Be Used in Patients with Sepsis or Burn Injuries or in Critically Ill Patients.
[85]  Pollitzer, R. (1959) Cholera. World Health Organization.
[86]  Barua, D. and Greenough, W.B. III. (1992) Cholera. Plenum Medical Book Company.
[87]  Howard-Jones, N. (1972) Cholera Therapy in the Nineteenth Century. Journal of the History of Medicine and Allied Sciences, 27, 373-395.
https://doi.org/10.1093/jhmas/xxvii.4.373

[88]  Greenough, W.B., Rosenberg, I.S., Gordon, R.S., Davies, B.I. and Benenson, A.S. (1964) Tetracycline in the Treatment of Cholera. The Lancet, 283, 355-357.
https://doi.org/10.1016/s0140-6736(64)92099-9

[89]  O’Shaughnessy, W.B. (1831) Proposal of A New Method of Treating the Blue Epidemic Cholera by the Injection of Highly-Oxygenised Salts into the Venous System. The Lancet, 17, 366-371.
https://doi.org/10.1016/s0140-6736(02)94163-2

[90]  O’Shaughnessy, W.B. (1831) Experiments on the Blood in Cholera. The Lancet, 17, Article 490.
https://doi.org/10.1016/s0140-6736(02)94389-8

[91]  Latta, T. (1832) Malignant Cholera. Documents Communicated by the Central Board of Health, London, Relative to the Treatment of Cholera by the Copious Injection of Aqueous and Saline Fluids into the Veins. The Lancet, 2, 274-277.
[92]  Latta, T. (1832) Saline Venous Injection in Cases of Malignant Cholera. The Lancet, 2, 208-209.
[93]  MacKintosh, J. (1832) Treatment of Cholera by Injection. The Lancet, 1, 368-370.
[94]  MacKintosh, J. (1832) Further Observations on Injection in Cholera. Edinburgh Medical and Surgical Journal, 38, 194-203.
[95]  Klencke, H. (1832) Die cholera-epidemie des jahres 1832. Leipzig.
[96]  Sédillot, C.E. (1836) Traité de médecine opératoire. Béchet.
[97]  Cantani, A. (1865) Sull’iniezione sottocutanea. Naples.
[98]  Awad, S., Allison, S.P. and Lobo, D.N. (2008) The History of 0.9% Saline. Clinical Nutrition, 27, 179-188.
https://doi.org/10.1016/j.clnu.2008.01.008

[99]  Baskett, T.F. (2002) William O’shaughnessy, Thomas Latta and the Origins of Intravenous Saline. Resuscitation, 55, 231-234.
https://doi.org/10.1016/s0300-9572(02)00294-0

[100]  Nalin, D.R. and Cash, R.A. (1970) Oral or Nasogastric Maintenance Therapy in Pediatric Cholera Patients. The Journal of Pediatrics, 77, 307-311.
[101]  Mahalanabis, D., Choudhuri, A.B., Bagchi, N.G., et al. (1973) Oral Fluid Therapy of Cholera among Bangladesh Refugees. Johns Hopkins Medical Journal, 132, 197-205.
[102]  Phillips, R.A. (1964) Water and Electrolyte Losses in Cholera. Federation Proceedings, 23, 705-712.
[103]  Hirschhorn, N., Kinzie, J.L., Sachar, D.B., Northrup, R.S., Taylor, J.O., Ahmad, S.Z., et al. (1968) Decrease in Net Stool Output in Cholera during Intestinal Perfusion with Glucose-Containing Solutions. New England Journal of Medicine, 279, 176-181.
https://doi.org/10.1056/nejm196807252790402

[104]  World Health Organization (1980) A Manual for the Treatment of Diarrhoea. WHO.
[105]  World Health Organization (2006) Oral Rehydration Salts: Production of the New ORS. WHO.
[106]  Ringer, S. (1883) A Further Contribution Regarding the Influence of the Different Constituents of the Blood on the Contraction of the Heart. The Journal of Physiology, 4, 29-42.
https://doi.org/10.1113/jphysiol.1883.sp000120

[107]  Miller, D.J. (2004) Sydney Ringer; Physiological Saline, Calcium and the Contraction of the Heart. The Journal of Physiology, 555, 585-587.
https://doi.org/10.1113/jphysiol.2004.060731

[108]  Simmons, D.H. (2002) A Primer on Ringer’s Solution. Physiologist, 45, 305-306.
[109]  Ringer, S. (1882) Regarding the Action of Hydrate of Soda, Hydrate of Ammonia, and Hydrate of Potash on the Ventricle of the Frog’s Heart. The Journal of Physiology, 3, 195-202.
https://doi.org/10.1113/jphysiol.1882.sp000095

[110]  Ringer, S. and Buxton, D.W. (1887) Concerning the Action of Calcium, Potassium, and Sodium Salts Upon the Eel’s Heart and Upon the Skeletal Muscles of the Frog. The Journal of Physiology, 8, 15-19.
https://doi.org/10.1113/jphysiol.1887.sp000239

[111]  Fye, W.B. (2003) Sydney Ringer, Calcium, and Cardiac Function. Circulation, 107, 2280-2282.
[112]  Gaskell, W.H. (1882) On the Rhythm of the Heart of the Frog, and on the Nature of the Action of the Vagus Nerve. Philosophical Transactions of the Royal Society of London, Series B: Biological Sciences, 173, 993-1033.
[113]  Coraboeuf, E. (1991) Bowditch and the Staircase Phenomenon, 1871. Trends in Cardiovascular Medicine, 1, 227-231.
[114]  Locke, F.S. (1901) Die Wirkung der metalle des blutplasmas und verschiedener zucker auf das isolirte säugethierherz. Zentralblatt für Physiologie, 14, 670-672.
[115]  Hearse, D.J., Stewart, D.A. and Chain, E.B. (1974) Recovery from Cardiac Bypass and Elective Cardiac Arrest: The Metabolic Consequences of Various Cardioplegic Procedures in the Isolated Rat Heart. Circulation Research, 35, 448-457.
https://doi.org/10.1161/01.res.35.3.448

[116]  Tyrode, M.V. (1910) The Mode of Action of Some Purgative Salts. Archives Internationales de Pharmacodynamie et de Thérapie, 20, 205-223.
[117]  Krebs, H.A. and Henseleit, K. (1932) Untersuchungen uber die Harnstoffbildung im Tierkörper. Biological Chemistry, 210, 33-66.
https://doi.org/10.1515/bchm2.1932.210.1-2.33

[118]  Krebs, H.A. (1970) The History of the Tricarboxylic Acid Cycle. Perspectives in Biology and Medicine, 14, 154-172.
https://doi.org/10.1353/pbm.1970.0001

[119]  Hartmann, A.F. and Senn, M.J.E. (1932) Studies in the Metabolism of Sodium R-Lactate. I. Response of Normal Human Subjects to the Intravenous Injection of Sodium R-Lactate. Journal of Clinical Investigation, 11, 327-335.
https://doi.org/10.1172/jci100414

[120]  Hartmann, A.F. and Senn, M.J.E. (1932) Studies in the Metabolism of Sodium R-Lactate. II. Response of Human Subjects with Acidosis to the Intravenous Injection of Sodium R-Lactate. Journal of Clinical Investigation, 11, 337-344.
https://doi.org/10.1172/jci100415

[121]  Morgan, T.J., Venkatesh, B. and Hall, J. (2004) Crystalloid Strong Ion Difference Determines Metabolic Acid-Base Change during Acute Normovolaemic Haemodilution. Intensive Care Medicine, 30, 1432-1437.
https://doi.org/10.1007/s00134-004-2176-x

[122]  Cone Jr., T.E. (1985) History of the Care and Feeding of the Premature Infant. Little, Brown.
[123]  Pearson, H.A. (2002) History of Pediatric Hematology Oncology. Pediatric Research, 52, 979-992.
https://doi.org/10.1203/00006450-200212000-00026

[124]  Davison, W.C. (1955) John Howland (1873-1926). The Journal of Pediatrics, 46, 473-486.
[125]  Howland, J. and Marriott, W.M. (1916) Acidosis Occurring with Diarrhea. Archives of Pediatrics and Adolescent Medicine, 11, 309-325.
https://doi.org/10.1001/archpedi.1916.04110110002001

[126]  Gamble, J.L. (1950) William McKim Marriott (1885-1936). The Journal of Pediatrics, 36, 239-241.
[127]  Blattner, R.J. (1959) Favism. The Journal of Pediatrics, 55, 531-533.
https://doi.org/10.1016/s0022-3476(59)80292-4

[128]  Gamble, J.L. (1942) Chemical Anatomy, Physiology and Pathology of Extracellular Fluid: A Lecture Syllabus. Harvard University Press.
[129]  Finberg, L. (1982) Gamble and Ross on Teaching. Pediatrics, 69, 122-124.
[130]  Marriott, W.M. and Hartmann, A.F. (1933) Croonian Lectures on the Newer Aspects of the Pathology of Nutrition in Infancy. The Lancet, 221, 1347-1352.
[131]  Gamble, J.L., Ross, G.S. and Tisdall, F.F. (1923) The Metabolism of Fixed Base During Fasting. Journal of Biological Chemistry, 57, 633-695.
https://doi.org/10.1016/s0021-9258(18)85480-1

[132]  Winters, R.W. (1965) Terminology of Acid-Base Disorders. Annals of Internal Medicine, 63, 873-884.
https://doi.org/10.7326/0003-4819-63-5-873

[133]  Talbot, N.B., Sobel, E.H., McArthur, J.W. and Crawford, J.D. (1952) Functional Endocrinology from Birth through Adolescence. Harvard University Press.
[134]  Crawford, J.D., Terry, M.E. and Rourke, G.M. (1950) Simplification of Drug Dosage Calculation by Application of the Surface Area Principle. Pediatrics, 5, 783-790.
https://doi.org/10.1542/peds.5.5.783

[135]  Butler, A.M., Talbot, N.B., Burnett, C.H., et al. (1947) Metabolic Studies in Diabetic Coma. Transactions of the Association of American Physicians, 60, 102-109.
[136]  Levine, S.Z., Wilson, J.R. and Gottschall, G. (1928) The Osmotic Pressure of Serum and Cerebro-Spinal Fluid. American Journal of Diseases of Children, 35, 195-200.
[137]  Holliday, M.A. and Segar, W.E. (1957) The Maintenance Need for Water in Parenteral Fluid Therapy. Pediatrics, 19, 823-832.
https://doi.org/10.1542/peds.19.5.823

[138]  Holliday, M.A., Ray, P.E. and Friedman, A.L. (2007) Fluid Therapy for Children: Facts, Fashions and Questions. Archives of Disease in Childhood, 92, 546-550.
https://doi.org/10.1136/adc.2006.106377

[139]  Segar, W.E. and Moore, W.W. (1968) The Regulation of Antidiuretic Hormone Release in Man. Journal of Clinical Investigation, 47, 2143-2151.
https://doi.org/10.1172/jci105900

[140]  Moritz, M.L. and Ayus, J.C. (2003) Prevention of Hospital-Acquired Hyponatremia: A Case for Using Isotonic Saline. Pediatrics, 111, 227-230.
https://doi.org/10.1542/peds.111.2.227

[141]  Halberthal, M. (2001) Lesson of the Week: Acute Hyponatraemia in Children Admitted to Hospital: Retrospective Analysis of Factors Contributing to Its Development and Resolution. BMJ, 322, 780-782.
https://doi.org/10.1136/bmj.322.7289.780

[142]  Neville, K.A. (2006) Isotonic Is Better than Hypotonic Saline for Intravenous Rehydration of Children with Gastroenteritis: A Prospective Randomised Study. Archives of Disease in Childhood, 91, 226-232.
https://doi.org/10.1136/adc.2005.084103

[143]  Darrow, D.C., Pratt, E.L., Flett, J., Gamble, A.H. and Wiese, H.F. (1949) Disturbances of Water and Electrolytes in Infantile Diarrhea. Pediatrics, 3, 129-156.
https://doi.org/10.1542/peds.3.2.129

[144]  Darrow, D.C. (1946) The Retention of Electrolyte during Recovery Fromsevere Dehydration Due to Diarrhea. The Journal of Pediatrics, 28, 515-540.
https://doi.org/10.1016/s0022-3476(46)80213-0

[145]  Shime, N., Hosokawa, T., Aoki, Y., et al. (2010) Intravenous Fluid Therapy for Pediatric Patients: Current Issues. Journal of Anesthesiology, 24, 730-740.
[146]  Wang, J., Xu, E. and Xiao, Y. (2014) Isotonic versus Hypotonic Maintenance IV Fluids in Hospitalized Children: A Meta-Analysis. Pediatrics, 133, 105-113.
https://doi.org/10.1542/peds.2013-2041

[147]  National Institute for Health and Care Excellence (2015) Intravenous Fluid Therapy in Children and Young People in Hospital (NG29). NICE.
[148]  Feld, L.G., Neuspiel, D.R., Foster, B.A., Leu, M.G., Garber, M.D., Austin, K., et al. (2018) Clinical Practice Guideline: Maintenance Intravenous Fluids in Children. Pediatrics, 142, e20183083.
https://doi.org/10.1542/peds.2018-3083

[149]  Maitland, K., Kiguli, S., Opoka, R.O., Engoru, C., Olupot-Olupot, P., Akech, S.O., et al. (2011) Mortality after Fluid Bolus in African Children with Severe Infection. New England Journal of Medicine, 364, 2483-2495.
https://doi.org/10.1056/nejmoa1101549

[150]  Maitland, K., George, E.C., Evans, J.A., Kiguli, S., Olupot-Olupot, P., Akech, S.O., et al. (2013) Exploring Mechanisms of Excess Mortality with Early Fluid Resuscitation: Insightsfrom the FEAST Trial. BMC Medicine, 11, Article No. 68.
https://doi.org/10.1186/1741-7015-11-68

[151]  Miller, T.E., Roche, A.M. and Mythen, M. (2015) Fluid Management and Goal-Directed Therapy as an Adjunct to Enhanced Recovery after Surgery (ERAS). Canadian Journal of Anesthesia, 62, 158-168.
https://doi.org/10.1007/s12630-014-0266-y

[152]  Miller, T.E. and Myles, P.S. (2019) Perioperative Fluid Therapy for Major Surgery. Anesthesiology, 130, 825-832.
https://doi.org/10.1097/aln.0000000000002603

[153]  Kehlet, H. (1997) Multimodal Approach to Control Postoperative Pathophysiology and Rehabilitation. British Journal of Anaesthesia, 78, 606-617.
https://doi.org/10.1093/bja/78.5.606

[154]  Fearon, K.C.H., Ljungqvist, O., Von Meyenfeldt, M., Revhaug, A., Dejong, C.H.C., Lassen, K., et al. (2005) Enhanced Recovery after Surgery: A Consensus Review of Clinical Care for Patients Undergoing Colonic Resection. Clinical Nutrition, 24, 466-477.
https://doi.org/10.1016/j.clnu.2005.02.002

[155]  Gustafsson, U.O., Scott, M.J., Hubner, M., Nygren, J., Demartines, N., Francis, N., et al. (2019) Guidelines for Perioperative Care in Elective Colorectal Surgery: Enhanced Recovery after Surgery (ERAS®) Society Recommendations: 2018. World Journal of Surgery, 43, 659-695.
https://doi.org/10.1007/s00268-018-4844-y

[156]  Engelman, D.T., Ben Ali, W., Williams, J.B., Perrault, L.P., Reddy, V.S., Arora, R.C., et al. (2019) Guidelines for Perioperative Care in Cardiac Surgery: Enhanced Recovery After Surgery Society Recommendations. JAMA Surgery, 154, 755-766.
https://doi.org/10.1001/jamasurg.2019.1153

[157]  Ljungqvist, O., Scott, M. and Fearon, K.C. (2017) Enhanced Recovery after Surgery: A Review. JAMA Surgery, 152, 292-298.
https://doi.org/10.1001/jamasurg.2016.4952

[158]  Smith, M.D., McCall, J., Plank, L., Herbison, G.P., Soop, M. and Nygren, J. (2014) Preoperative Carbohydrate Treatment for Enhancing Recovery after Elective Surgery. Cochrane Database of Systematic Reviews, No. 8, CD009161.
https://doi.org/10.1002/14651858.cd009161.pub2

[159]  Nicholson, A., Lowe, M.C., Parker, J., Lewis, S.R., Alderson, P. and Smith, A.F. (2014) Systematic Review and Meta-Analysis of Enhanced Recovery Programmes in Surgical Patients. British Journal of Surgery, 101, 172-188.
https://doi.org/10.1002/bjs.9394

[160]  Wainwright, T.W., Gill, M., McDonald, D.A., Middleton, R.G., Reed, M., Sahota, O., et al. (2019) Consensus Statement for Perioperative Care in Total Hip Replacement and Total Knee Replacement Surgery: Enhanced Recovery after Surgery (ERAS®) Society Recommendations. Acta Orthopaedica, 91, 3-19.
https://doi.org/10.1080/17453674.2019.1683790

[161]  Pearse, R.M., Harrison, D.A., MacDonald, N., Gillies, M.A., Blunt, M., Ackland, G., et al. (2014) Effect of a Perioperative, Cardiac Output-Guided Hemodynamic Therapy Algorithm on Outcomes Following Major Gastrointestinal Surgery. JAMA, 311, 2181-2190.
https://doi.org/10.1001/jama.2014.5305

[162]  Marik, P.E., Cavallazzi, R., Vasu, T. and Hirani, A. (2009) Dynamic Changes in Arterial Waveform Derived Variables and Fluid Responsiveness in Mechanically Ventilated Patients: A Systematic Review of the Literature. Critical Care Medicine, 37, 2642-2647.
https://doi.org/10.1097/ccm.0b013e3181a590da

[163]  Saugel, B., Cecconi, M., Wagner, J.Y. and Reuter, D.A. (2015) Noninvasive Continuous Cardiac Output Monitoring in Perioperative and Intensive Care Medicine. British Journal of Anaesthesia, 114, 562-575.
https://doi.org/10.1093/bja/aeu447

[164]  Grocott, M.P.W., Dushianthan, A., Hamilton, M.A., Mythen, M.G., Harrison, D. and Rowan, K. (2013) Perioperative Increase in Global Blood Flow to Explicit Defined Goals and Outcomes after Surgery: A Cochrane Systematic Review. British Journal of Anaesthesia, 111, 535-548.
https://doi.org/10.1093/bja/aet155

[165]  Rollins, K.E. and Lobo, D.N. (2016) Intraoperative Goal-Directed Fluid Therapy in Elective Major Abdominal Surgery: A Meta-Analysis of Randomized Controlled Trials. Annals of Surgery, 263, 465-476.
https://doi.org/10.1097/sla.0000000000001366

[166]  Challand, C., Struthers, R., Sneyd, J.R., Erasmus, P.D., Mellor, N., Hosie, K.B., et al. (2012) Randomized Controlled Trial of Intraoperative Goal-Directed Fluid Therapy in Aerobically Fit and Unfit Patients Having Major Colorectal Surgery. British Journal of Anaesthesia, 108, 53-62.
https://doi.org/10.1093/bja/aer273

[167]  Finfer, S., Bellomo, R., Boyce, N., et al. (2004) A Comparison of Albumin and Saline for Fluid Resuscitation in the Intensive Care Unit. The New England Journal of Medicine, 350, 2247-2256.
[168]  Annane, D. (2013) Effects of Fluid Resuscitation with Colloids vs Crystalloids on Mortality in Critically Ill Patients Presenting with Hypovolemic Shock: The Cristal Randomized Trial. JAMA, 310, 1809-1817.
https://doi.org/10.1001/jama.2013.280502

[169]  Semler, M.W., Self, W.H., Wanderer, J.P., Ehrenfeld, J.M., Wang, L., Byrne, D.W., et al. (2018) Balanced Crystalloids versus Saline in Critically Ill Adults. New England Journal of Medicine, 378, 829-839.
https://doi.org/10.1056/nejmoa1711584

[170]  Self, W.H., Semler, M.W., Wanderer, J.P., Wang, L., Byrne, D.W., Collins, S.P., et al. (2018) Balanced Crystalloids versus Saline in Noncritically Ill Adults. New England Journal of Medicine, 378, 819-828.
https://doi.org/10.1056/nejmoa1711586

[171]  Zampieri, F.G., Machado, F.R., Biondi, R.S., Freitas, F.G.R., Veiga, V.C., Figueiredo, R.C., et al. (2021) Effect of Intravenous Fluid Treatment with a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA, 326, 818-829.
https://doi.org/10.1001/jama.2021.11684

[172]  Myburgh, J.A. and Mythen, M.G. (2013) Resuscitation Fluids. New England Journal of Medicine, 369, 1243-1251.
https://doi.org/10.1056/nejmra1208627

[173]  Stewart, P.A. (1983) Modern Quantitative Acid-Base Chemistry. Canadian Journal of Physiology and Pharmacology, 61, 1444-1461.
https://doi.org/10.1139/y83-207

[174]  Morgan, T.J. (2004) The Meaning of Acid-Base Abnormalities in the Intensive Care Unit: Part III—Effects of Fluid Administration. Critical Care, 9, 204-211.
https://doi.org/10.1186/cc2946

[175]  Malbrain, M.L.N.G., Marik, P.E., Witters, I., Cordemans, C., Kirkpatrick, A.W., Roberts, D.J., et al. (2014) Fluid Overload, De-Resuscitation, and Outcomes in Critically Ill or Injured Patients: A Systematic Review with Suggestions for Clinical Practice. Anestezjologia Intensywna Terapia, 46, 361-380.
https://doi.org/10.5603/ait.2014.0060

[176]  Komorowski, M., Celi, L.A., Badawi, O., Gordon, A.C. and Faisal, A.A. (2018) The Artificial Intelligence Clinician Learns Optimal Treatment Strategies for Sepsis in Intensive Care. Nature Medicine, 24, 1716-1720.
https://doi.org/10.1038/s41591-018-0213-5

[177]  Bose, E. and Magder, S. (2022) Artificial Intelligence and Machine Learning in Intensive Care Medicine. Intensive Care Medicine, 48, 589-592.
[178]  Goodnough, L.T., Shander, A. and Riou, B. (2012) Patient Blood Management. Anesthesiology, 116, 1367-1376.
https://doi.org/10.1097/aln.0b013e318254d1a3

[179]  Shander, A., Hofmann, A., Ozawa, S., Theusinger, O.M., Gombotz, H. and Spahn, D.R. (2010) Activity‐Based Costs of Blood Transfusions in Surgical Patients at Four Hospitals. Transfusion, 50, 753-765.
https://doi.org/10.1111/j.1537-2995.2009.02518.x

[180]  Leahy, M.F., Hofmann, A., Towler, S., Trentino, K.M., Burrows, S.A., Swain, S.G., et al. (2017) Improved Outcomes and Reduced Costs Associated with a Health‐System-Wide Patient Blood Management Program: A Retrospective Observational Study in Four Major Adult Tertiary‐Care Hospitals. Transfusion, 57, 1347-1358.
https://doi.org/10.1111/trf.14006

[181]  World Health Assembly (2010) Availability, Safety and Quality of Blood Products: Report by the Secretariat. 63rd World Health Assembly, WHO.
[182]  Spahn, D.R., Theusinger, O.M. and Hofmann, A. (2012) Patient Blood Management Is a Win-Win: A Wake-Up Call. British Journal of Anaesthesia, 108, 889-892.
https://doi.org/10.1093/bja/aes166

[183]  Meybohm, P., Froessler, B., Goodnough, L.T., Klein, A.A., Muñoz, M., Murphy, M.F., et al. (2017) “Simplified International Recommendations for the Implementation of Patient Blood Management” (SIR4PBM). Perioperative Medicine, 6, Article No. 5.
https://doi.org/10.1186/s13741-017-0061-8

[184]  Musallam, K.M., Tamim, H.M., Richards, T., Spahn, D.R., Rosendaal, F.R., Habbal, A., et al. (2011) Preoperative Anaemia and Postoperative Outcomes in Non-Cardiac Surgery: A Retrospective Cohort Study. The Lancet, 378, 1396-1407.
https://doi.org/10.1016/s0140-6736(11)61381-0

[185]  Baron, D.M., Hochrieser, H., Posch, M., Metnitz, B., Rhodes, A., Moreno, R.P., et al. (2014) Preoperative Anaemia Is Associated with Poor Clinical Outcome in Non-Cardiac Surgery Patients. British Journal of Anaesthesia, 113, 416-423.
https://doi.org/10.1093/bja/aeu098

[186]  Muñoz, M., Acheson, A.G., Auerbach, M., Besser, M., Habler, O., Kehlet, H., et al. (2017) International Consensus Statement on the Peri‐Operative Management of Anaemia and Iron Deficiency. Anaesthesia, 72, 233-247.
https://doi.org/10.1111/anae.13773

[187]  Ganz, T. and Nemeth, E. (2012) Hepcidin and Iron Homeostasis. Biochimica et Biophysica Acta (BBA)-Molecular Cell Research, 1823, 1434-1443.
https://doi.org/10.1016/j.bbamcr.2012.01.014

[188]  Green, R., Allen, L.H., Bjørke-Monsen, A., Brito, A., Guéant, J., Miller, J.W., et al. (2017) Vitamin B12 Deficiency. Nature Reviews Disease Primers, 3, Article No. 17040.
https://doi.org/10.1038/nrdp.2017.40
[189]  Froessler, B., Palm, P., Weber, I., Hodyl, N.A., Singh, R. and Murphy, E.M. (2016) The Important Role for Intravenous Iron in Perioperative Patient Blood Management in Major Abdominal Surgery: A Randomized Controlled Trial. Annals of Surgery, 264, 41-46.
https://doi.org/10.1097/sla.0000000000001646

[190]  Richards, T., Baikady, R.R., Clevenger, B., Butcher, A., Abeysiri, S., Chau, M., et al. (2020) Preoperative Intravenous Iron to Treat Anaemia before Major Abdominal Surgery (PREVENTT): A Randomised, Double-Blind, Controlled Trial. The Lancet, 396, 1353-1361.
https://doi.org/10.1016/s0140-6736(20)31539-7

[191]  Rustomjee, K.J., Delaforce, A., McGrath, K., et al. (2021) Intravenous Iron in the Perioperative Setting for the Treatment of Anaemia: An Update on Efficacy and Safety. Anaesthesia and Intensive Care, 49, 180-191.
[192]  Spahn, D.R., Schoenrath, F., Spahn, G.H., Seifert, B., Stein, P., Theusinger, O.M., et al. (2019) Effect of Ultra-Short-Term Treatment of Patients with Iron Deficiency or Anaemia Undergoing Cardiac Surgery: A Prospective Randomised Trial. The Lancet, 393, 2201-2212.
https://doi.org/10.1016/s0140-6736(18)32555-8

[193]  Alsaleh, K., Alotaibi, G.S., Almodaimegh, H.S., Aleem, A.A. and Kouroukis, C.T. (2013) The Use of Preoperative Erythropoiesis-Stimulating Agents (ESAS) in Patients Who Underwent Knee or Hip Arthroplasty: A Meta-Analysis of Randomized Clinical trials. The Journal of Arthroplasty, 28, 1463-1472.
https://doi.org/10.1016/j.arth.2013.01.024

[194]  Clevenger, B., Gurusamy, K., Klein, A.A., Murphy, G.J., Anker, S.D. and Richards, T. (2016) Systematic Review and Meta-Analysis of Iron Therapy in Anaemic Adults without Chronic Kidney Disease: Updated and Abridged Cochrane Review. European Journal of Heart Failure, 18, 774-785.
https://doi.org/10.1002/ejhf.514

[195]  Ker, K., Edwards, P., Perel, P., Shakur, H. and Roberts, I. (2012) Effect of Tranexamic Acid on Surgical Bleeding: Systematic Review and Cumulative Meta-Analysis. BMJ, 344, e3054-e3054.
https://doi.org/10.1136/bmj.e3054

[196]  Whiting, P., Al, M., Westwood, M., Ramos, I.C., Ryder, S., Armstrong, N., et al. (2015) Viscoelastic Point-of-Care Testing to Assist with the Diagnosis, Management and Monitoring of Haemostasis: A Systematic Review and Cost-Effectiveness Analysis. Health Technology Assessment, 19, 1-228.
https://doi.org/10.3310/hta19580

[197]  Carless, P.A., Henry, D.A., Moxey, A.J., et al. (2010) Cell Salvage for Minimising Perioperative Allogeneic Blood Transfusion. Cochrane Database of Systematic Reviews, No. 4, CD001888.
[198]  Hébert, P.C., Wells, G., Blajchman, M.A., Marshall, J., Martin, C., Pagliarello, G., et al. (1999) A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. New England Journal of Medicine, 340, 409-417.
https://doi.org/10.1056/nejm199902113400601

[199]  Carson, J.L., Terrin, M.L., Noveck, H., Sanders, D.W., Chaitman, B.R., Rhoads, G.G., et al. (2011) Liberal or Restrictive Transfusion in High-Risk Patients after Hip Surgery. New England Journal of Medicine, 365, 2453-2462.
https://doi.org/10.1056/nejmoa1012452

[200]  Meybohm, P., Richards, T., Isbister, J., Hofmann, A., Shander, A., Goodnough, L.T., et al. (2017) Patient Blood Management Bundles to Facilitate Implementation. Transfusion Medicine Reviews, 31, 62-71.
https://doi.org/10.1016/j.tmrv.2016.05.012

[201]  Meybohm, P., Herrmann, E., Steinbicker, A.U., Wittmann, M., Gruenewald, M., Fischer, D., et al. (2016) Patient Blood Management Is Associated with a Substantial Reduction of Red Blood Cell Utilization and Safe for Patient’s Outcome: A Prospective, Multicenter Cohort Study with a Noninferiority Design. Annals of Surgery, 264, 203-211.
https://doi.org/10.1097/sla.0000000000001747

[202]  Froessler, B., Rueger, A. and Connolly, M. (2018) Assessing the Costs and Benefits of Perioperative Iron Deficiency Anemia Management with Ferric Carboxymaltose in Germany. Risk Management and Healthcare Policy, 11, 77-82.
https://doi.org/10.2147/rmhp.s157379

[203]  Klein, A.A., Chau, M., Iohom, G., et al. (2020) Patient Blood Management in Europe: Surveys on Anaemia Prevalence, Iron Deficiency Diagnosis, and the Use of Intravenous Iron. European Journal of Anaesthesiology, 37, 1015-1025.
[204]  Shander, A. and Goodnough, L.T. (2006) Objectives and Limitations of Bloodless Medical Care. Current Opinion in Hematology, 13, 462-470.
https://doi.org/10.1097/01.moh.0000245692.32085.bd

[205]  Vamvakas, E.C. and Blajchman, M.A. (2009) Transfusion-Related Mortality: The Ongoing Risks of Allogeneic Blood Transfusion and the Available Strategies for Their Prevention. Blood, 113, 3406-3417.
https://doi.org/10.1182/blood-2008-10-167643

[206]  Clark, L.C. and Gollan, F. (1966) Survival of Mammals Breathing Organic Liquids Equilibrated with Oxygen at Atmospheric Pressure. Science, 152, 1755-1756.
https://doi.org/10.1126/science.152.3730.1755

[207]  Spahn, D.R., van Brempt, R., Theilmeier, G., Reibold, J., Welte, M., Heinzerling, H., et al. (1999) Perflubron Emulsion Delays Blood Transfusions in Orthopedic Surgery. Anesthesiology, 91, 1195-1195.
https://doi.org/10.1097/00000542-199911000-00009

[208]  Keipert, P.E., Otto, S., Flaim, S.F., Weers, J.G., Schutt, E.A., Pelura, T.J., et al. (1994) Influence of Perflubron Emulsion Particle Size on Blood Half-Life and Febrile Response in Rats. Artificial Cells, Blood Substitutes, and Biotechnology, 22, 1169-1174.
https://doi.org/10.3109/10731199409138812

[209]  Buehler, P.W. and Alayash, A.I. (2008) All Hemoglobin-Based Oxygen Carriers Are Not Created Equally. Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics, 1784, 1378-1381.
https://doi.org/10.1016/j.bbapap.2007.12.009

[210]  Natanson, C., Kern, S.J., Lurie, P., Banks, S.M. and Wolfe, S.M. (2008) Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death. JAMA, 299, 2304-2312.
https://doi.org/10.1001/jama.299.19.jrv80007

[211]  Riess, J.G. (2006) Perfluorocarbon-Based Oxygen Delivery. Artificial Cells, Blood Substitutes, and Biotechnology, 34, 567-580.
https://doi.org/10.1080/10731190600973824

[212]  Riess, J.G. (2005) Understanding the Fundamentals of Perfluorocarbons and Perfluorocarbon Emulsions Relevant to in Vivo Oxygen Delivery. Artificial Cells, Blood Substitutes, and Biotechnology, 33, 47-63.
https://doi.org/10.1081/bio-200046659

[213]  Alayash, A.I. (2019) Mechanisms of Toxicity and Modulation of Hemoglobin-Based Oxygen Carriers. Shock, 52, 41-49.
https://doi.org/10.1097/shk.0000000000001044

[214]  Sakai, H. (2017) Overview of Potential Clinical Applications of Hemoglobin Vesicles (HBV) as Artificial Red Cells, Evidenced by Preclinical Studies of the Academic Research Consortium. Journal of Functional Biomaterials, 8, Article 10.
https://doi.org/10.3390/jfb8010010

[215]  Kure, T. and Sakai, H. (2021) Preparation of Artificial Red Blood Cells (Hemoglobin Vesicles) Using the Rotation-Revolution Mixer for High Encapsulation Efficiency. ACS Biomaterials Science & Engineering, 7, 2835-2844.
https://doi.org/10.1021/acsbiomaterials.1c00424

[216]  Sakai, H., Sato, A., Masuda, K., Takeoka, S. and Tsuchida, E. (2008) Encapsulation of Concentrated Hemoglobin Solution in Phospholipid Vesicles Retards the Reaction with NO, but Not CO, by Intracellular Diffusion Barrier. Journal of Biological Chemistry, 283, 1508-1517.
https://doi.org/10.1074/jbc.m707660200

[217]  Sakai, H., Masada, Y., Horinouchi, H., Ikeda, E., Sou, K., Takeoka, S., et al. (2004) Physiological Capacity of the Reticuloendothelial System for the Degradation of Hemoglobin Vesicles (Artificial Oxygen Carriers) after Massive Intravenous Doses by Daily Repeated Infusions for 14 Days. The Journal of Pharmacology and Experimental Therapeutics, 311, 874-884.
https://doi.org/10.1124/jpet.104.073049

[218]  Azuma, H., Amano, T., Kamiyama, N., Takehara, N., Jingu, M., Takagi, H., et al. (2022) First-in-Human Phase 1 Trial of Hemoglobin Vesicles as Artificial Red Blood Cells Developed for Use as a Transfusion Alternative. Blood Advances, 6, 5711-5715.
https://doi.org/10.1182/bloodadvances.2022007977

[219]  Jahr, J.S., Guinn, N.R., Lowery, D.R., Shore-Lesserson, L. and Shander, A. (2021) Blood Substitutes and Oxygen Therapeutics: A Review. Anesthesia & Analgesia, 132, 119-129.
https://doi.org/10.1213/ane.0000000000003957

[220]  Yuki, Y., Hagisawa, K., Kinoshita, M., Ishibashi, H., Kaneko, K., Ishida, O., et al. (2021) Efficacy of Resuscitative Infusion with Hemoglobin Vesicles in Rabbits with Massive Obstetric Hemorrhage. American Journal of Obstetrics and Gynecology, 224, 398.e1-398.e11.
https://doi.org/10.1016/j.ajog.2020.09.010

[221]  Mohanto, N., Panda, A.K., Pramanik, N., et al. (2022) Current Perspectives of Artificial Oxygen Carriers as Red Blood Cell Substitutes: A Review of Old to Cutting-Edge Technologies. Molecular Pharmaceutics, 19, 2121-2142.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133